NASDAQ · Analyst Forecast

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Forecast & Price Target

$119.04 NASDAQ: RYTM Market Cap $8.25B

Price as of Nov 18, 2026 close · Analyst estimates retrieved Nov 19, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Rhythm Pharmaceuticals, Inc. (RYTM), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Rhythm Pharmaceuticals, Inc., analysts forecast revenue rising from $188.99M in 2025 to $1.76B in 2030; the average estimate for 2030 earnings per share is $10.00; with published estimates ranging from $7.50 to $11.47; 14 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$119.04
Consensus targetThe average of the price targets analysts have published.$144.43
Median targetThe middle target, less affected by a single outlier.$154.00
Highest targetThe most optimistic published target.$160.00
Lowest targetThe most pessimistic published target.$120.00
Difference from priceHow far the consensus target sits from today’s price.+21.3%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$185.19M$188.99M$195.38M14
2026$319.80M$332.31M$342.87M13
2027$520.77M$573.24M$619.21M14
2028$596.86M$870.50M$1.04B14
2029$1.02B$1.26B$1.41B8
2030$1.42B$1.76B$1.96B12

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$3.35−$3.17−$2.9014
2026−$8.18−$5.05−$2.3513
2027−$2.72−$1.10−$0.4614
2028−$2.36$1.67$3.6614
2029$4.19$5.58$6.408
2030$7.50$10.00$11.4712

Rhythm Pharmaceuticals, Inc. (RYTM) forecast — frequently asked questions

What is the analyst price target for Rhythm Pharmaceuticals, Inc.?

Analysts covering Rhythm Pharmaceuticals, Inc. (RYTM) have a consensus price target of $144.43, 21.3% above the current price of $119.04. Published targets range from $120.00 to $160.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Rhythm Pharmaceuticals, Inc.'s earnings?

The average analyst estimate for Rhythm Pharmaceuticals, Inc. (RYTM) earnings per share in 2030 is 10.00, with individual estimates between 7.50 and 11.47.

How much revenue is Rhythm Pharmaceuticals, Inc. expected to make?

Analysts forecast Rhythm Pharmaceuticals, Inc. (RYTM) revenue of $1.76B in 2030, based on 12 published estimates.

How many analysts cover RYTM?

14 analysts contribute estimates for Rhythm Pharmaceuticals, Inc. (RYTM). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.